Platinum Plus Gemcitabine as the Most Effective Regimen in the First Line of Chemotherapy in Advanced Squamous Cell Lung Cancer

2017 ◽  
Vol 2 (1) ◽  
Keyword(s):  
Lung Cancer ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Squamous Cell Lung Cancer ◽  
First Line ◽  
Effective Regimen

scholarly journals First‐line immune checkpoint therapy in metastatic squamous cell lung cancer harboring both EGFR mutation and high expression of PD‐L1 : A case report

2020 ◽  
Vol 11 (6) ◽  
pp. 1716-1719
Author(s):  
Kosuke Hamai ◽  
Hiroki Tanahashi ◽  
Sayaka Ueno ◽  
Hanae Konishi ◽  
Mirai Matsumura ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Case Report ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Immune Checkpoint ◽  
Egfr Mutation ◽  
High Expression ◽  
Squamous Cell Lung Cancer ◽  
First Line

scholarly journals Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer

2019 ◽  
Vol 10 (9) ◽  
pp. 1764-1769
Author(s):  
Hirokazu Taniguchi ◽  
Hiroyuki Yamaguchi ◽  
Yosuke Dotsu ◽  
Midori Shimada ◽  
Hiroshi Gyotoku ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase Ii ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Squamous Cell Lung Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

scholarly journals First-Line Chemotherapy with Carboplatin and Docetaxel for Advanced Squamous Cell Lung Cancer

2012 ◽  
Vol 23 ◽  
pp. xi134
Author(s):  
T. Terashima ◽  
T. Matsuzaki ◽  
H. Fujiwara ◽  
A. Nakaya ◽  
K. Matsumoto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Squamous Cell Lung Cancer ◽  
First Line ◽  
Line Chemotherapy

First line crizotinib in anaplastic lymphoma kinase (ALK) rearranged squamous cell lung cancer

Lung Cancer ◽  
2015 ◽  
Vol 90 (3) ◽  
pp. 614-616 ◽  
Author(s):  
Romana E. Mikes ◽  
Franziska Jordan ◽  
Georg Hutarew ◽  
Michael Studnicka
Keyword(s):  
Lung Cancer ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Anaplastic Lymphoma Kinase ◽  
Squamous Cell Lung Cancer ◽  
First Line ◽  
Anaplastic Lymphoma

Necitumumab: a new option for first-line treatment of squamous cell lung cancer

2018 ◽  
Vol 14 (8) ◽  
pp. 765-772 ◽  
Author(s):  
Elizabeth Jiménez Aguilar ◽  
Jon Zugazagoitia Fraile ◽  
Luis Paz-Ares Rodríguez
Keyword(s):  
Lung Cancer ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Squamous Cell Lung Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Addition of apatorsen, an inhibitor of Hsp27, to first-line gemcitabine/carboplatin in advanced squamous cell lung cancer: Design of the Cedar study.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. TPS8111-TPS8111 ◽  
Author(s):  
Peter Schmid ◽  
Dakshinmoorthy Muthukumar ◽  
Fiona Helen Blackhall ◽  
Jason Francis Lester ◽  
Sarah Khan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Squamous Cell Lung Cancer ◽  
First Line
Sign in / Sign up

Export Citation Format

Share Document